Posted in | News | Industrial Robotics

Halliburton Introduces Equiflow® Density Autonomous Inflow Control Device to Enhance Hydrocarbon Recovery

Halliburton Company today introduced the EquiFlow® Density autonomous inflow control device (AICD). This first-of-its-kind device addresses reservoir fluid uncertainties and allows the operator to enhance hydrocarbon recovery in wells where current autonomous technologies are limited.

EquiFlow Density uses an innovative density amplifier designed to differentiate reservoir fluids. It incorporates a fluid selector to magnify density forces by creating artificial gravity while making the device completely orientation neutral. The fluid selector opens or closes autonomously to restrict water without any surface intervention. The tool provides a meaningful reduction in water influx, which is typically treated at the surface.

“Most autonomous ICDs rely on reservoir fluid viscosity contrast to differentiate the fluids being produced, but oil and water frequently appear at similar viscosities,” said David Loveless, vice president, Halliburton Completion Tools. “EquiFlow Density AICD differentiates itself by producing and restricting downhole fluids using density, even when the viscosities are identical. This allows operators to optimize hydrocarbon production in difficult wells where current autonomous technologies are not effectively able to separate the water from the desired oil.”

EquiFlow Density AICD is part of Halliburton’s Advanced Completions portfolio, purposely engineered to improve reservoir management, enhance hydrocarbon recovery, and optimize production to provide higher revenue potential and increased asset value.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.